PUBLISHER: BCC Research | PRODUCT CODE: 1813334
PUBLISHER: BCC Research | PRODUCT CODE: 1813334
The Chinese Market for DNA Sequencing
The Chinese DNA sequencing market is expected to grow from $1.2 billion in 2025 and is projected to reach $3.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 21.5% during the forecast period of 2025 to 2030.
The Next-generation sequencing (NGS) segment of Chinese DNA sequencing market is expected to grow from $892.6 million in 2025 and is projected to reach $2.4 billion by the end of 2030, at a CAGR of 22.1% during the forecast period of 2025 to 2030.
The third-generation sequencing segment of Chinese DNA sequencing market is expected to grow from $162 million in 2025 and is projected to reach $432 million by the end of 2030, at a CAGR of 21.7% during the forecast period of 2025 to 2030.
Report Scope
This report provides an overview of the Chinese market for DNA sequencing and analyzes market trends. It includes revenue ($ million) for the base year data for 2024 and estimated data for 2025, and compound annual growth rate (CAGR) forecasts through the end of 2030. The market analyzed by products and services, technology, applications, end-users and provinces. The provinces covered in this study include Beijing, Shanghai, Guangdong and others.
In this report, "China" refers to mainland China and does not include Hong Kong, Macao, or Taiwan. Mainland China has 31 province-level regions, including 22 provinces, four province-level municipalities (cities) and five province-level autonomous regions. Beijing, Shanghai and Guangdong are also discussed in this report.
The report also highlights developments related to venture capital and corporate investments, regulatory trends and enterprise strategies of key firms and potential future opportunities stemming from AI-driven sequences of precision medicine and population genomics programs. The combination of in-depth market forecasts, macroeconomic analysis and tariff assessments makes this report a critical resource for stakeholders, investors and policymakers seeking to understand and take advantage of the rapidly developing Chinese DNA sequencing sector. The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It also analyzes emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape, which provides the ranking or share of key companies. It also has a dedicated section of company profiles that covers details of leading companies.
Report Includes
- 16 data tables and 40 additional tables
- Overview and an analysis of the Chinese market for DNA sequencing technologies
- Analyses of the Chinese market trends, with revenue data from 2022-2024, estimates for 2025, and projected CAGRs through 2030
- Estimates of the size and revenue prospects for the market, along with a market share analysis by product and service type, technology, application, end user and provinces
- Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, regulations and the impacts of macroeconomic variables
- Insights derived from Porter's Five Forces model and global supply chain analysis
- Discussion of emerging trends and opportunities in next-generation DNA sequencing technologies and applications in research and clinical markets
- Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Profiles of the leading companies, including BGI, Novogene Co. Ltd., Berry Genomics, Annoroad Gene Technology, and Burning Rock Dx.
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Technological Advances
- Market Dynamics and Growth Factors
- Segmental Analysis
- Conclusion
Chapter 2 Market Overview
- Overview and Market Definition
- Porter's Five Forces Analysis
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential for New Entrants
- Competition in the Industry
- Threat of Substitutes
- Impact of the U.S. Tariffs
- Direct Impact on Global Companies (e.g., Illumina, Thermo Fisher Scientific)
- Indirect Impact: Catalyzing Domestic Growth and Self-Sufficiency in China
- Impact on Market Structure and Long-Term Dynamics
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Government Investment and National Strategic Initiatives
- Innovation and Technological Advances - Making Sequencing Affordable
- Growing Demand for Precision Medicine and Oncology Genomics
- Market Restraints
- High Cost of DNA Sequencing Technologies and Operational Barriers
- Regulatory Complexity and Data Privacy Challenges
- Market Opportunities
- Expansion of Precision Medicine
- Growth in Non-invasive Prenatal Testing
Chapter 4 Regulatory Landscape
- Chinese DNA Sequencing Industry Regulatory Scenario
- Key Regulatory Authorities
- Human Genetic Resources (HGR) Regulations
- Clinical Use of DNA Sequencing
Chapter 5 Emerging Technologies and Developments
- Emerging Technologies
- Long-Read Sequencing Technologies
- Single-Molecule Real-Time (SMRT) Sequencing
- Nanopore Sequencing
- Spatial Genomics and Transcriptomics
- Single-Cell DNA Sequencing
- Ultra-Low-Input Sequencing
- CRISPR-Cas9 and Genome Editing Integration with Sequencing Technologies
- Artificial Intelligence (AI) and Machine Learning in DNA Sequencing
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Chinese DNA Sequencing Market Analysis by Product and Service
- Instruments and Consumables
- Services
- Chinese DNA Sequencing Market Analysis, by Technology
- Next-Generation Sequencing (NGS)
- Third-Generation Sequencing
- Sanger Sequencing
- Pyrosequencing
- Chinese DNA Sequencing Market Analysis, by Application
- Biopharma
- Microbiology
- Agriculture
- Chinese DNA Sequencing Market Analysis, by End User
- Academic and Research Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Clinical Research
- Chinese DNA Sequencing Market Analysis, by Province
- Guangdong
- Beijing
- Shanghai
- Other Chinese Regional Markets
Chapter 7 Competitive Landscape
- Overview
- Domestic Companies
- International Companies
Chapter 8 Appendix
- Methodology
- References
- Abbreviations
- Company Profiles
- AGILENT TECHNOLOGIES INC.
- ANNOROAD GENE TECHNOLOGY
- BERRY GENOMICS
- BGI
- BURNING ROCK DX
- CAPITALBIO TECHNOLOGY CO. LTD.
- ILLUMINA INC.
- NOVOGENE CO. LTD.
- OXFORD NANOPORE TECHNOLOGIES PLC
- PACBIO
- THERMO FISHER SCIENTIFIC INC.
- Emerging Start-ups/Market Disruptors
List of Tables
- Summary Table : Chinese Market for DNA Sequencing, by Technology, Through 2030
- Table 1 : Chinese Market for DNA Sequencing, by Product and Service, Through 2030
- Table 2 : DNA Sequencing Instruments and Consumables Offered by Major Companies
- Table 3 : Chinese Market for DNA Sequencing Instruments and Consumables, by Workflow, Through 2030
- Table 4 : Chinese Market for DNA Sequencing Services, by Workflow, Through 2030
- Table 5 : Chinese Market for DNA Sequencing, by Technology, Through 2030
- Table 6 : Chinese Market for DNA Sequencing, by Application, Through 2030
- Table 7 : Chinese Market for DNA Sequencing, by End User, Through 2030
- Table 8 : Chinese Market for DNA Sequencing, by Province, Through 2030
- Table 9 : Leading Chinese DNA Sequencing Companies, 2024
- Table 10 : Leading Chinese DNA Sequencing Companies' Strategic Developments, 2023-2025
- Table 11 : Information Sources for this Report
- Table 12 : Glossary of Terms Used in the Chinese DNA Sequencing Market
- Table 13 : Agilent Technologies Inc.: Company Snapshot
- Table 14 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
- Table 15 : Agilent Technologies Inc.: Product Portfolio
- Table 16 : Agilent Technologies Inc.: News/Key Developments, 2023-2024
- Table 17 : Annoroad Gene Technology: Company Snapshot
- Table 18 : Annoroad Gene Technology: Product Portfolio
- Table 19 : Annoroad Gene Technology: News/Key Developments, 2024
- Table 20 : Berry Genomics: Company Snapshot
- Table 21 : Berry Genomics: Financial Performance, FY 2023 and 2024
- Table 22 : Berry Genomics: Product Portfolio
- Table 23 : Berry Genomics: News/Key Developments, 2024-2025
- Table 24 : BGI: Company Snapshot
- Table 25 : BGI: Financial Performance, FY 2023 and 2024
- Table 26 : BGI: Product Portfolio
- Table 27 : BGI: News/Key Developments, 2025
- Table 28 : Burning Rock Dx: Company Snapshot
- Table 29 : Burning Rock Dx: Financial Performance, FY 2022 and 2023
- Table 30 : Burning Rock Dx: Product Portfolio
- Table 31 : Burning Rock Dx: News/Key Developments, 2023-2024
- Table 32 : CapitalBio Technology Co. Ltd.: Company Snapshot
- Table 33 : CapitalBio Technology Co. Ltd.: Product Portfolio
- Table 34 : CapitalBio Technology Co. Ltd.: News/Key Developments, 2024-2025
- Table 35 : Illumina Inc.: Company Snapshot
- Table 36 : Illumina Inc.: Financial Performance, FY 2023 and 2024
- Table 37 : Illumina Inc.: Product Portfolio
- Table 38 : Illumina Inc.: News/Key Developments, 2023-2024
- Table 39 : Novogene Co. Ltd.: Company Snapshot
- Table 40 : Novogene Co. Ltd.: Financial Performance, FY 2023 and 2024
- Table 41 : Novogene Co. Ltd.: Product Portfolio
- Table 42 : Novogene Co. Ltd.: News/Key Developments, 2023-2024
- Table 43 : Oxford Nanopore Technologies plc: Company Snapshot
- Table 44 : Oxford Nanopore Technologies plc: Financial Performance, FY 2023 and 2024
- Table 45 : Oxford Nanopore Technologies plc: Product Portfolio
- Table 46 : Oxford Nanopore Technologies plc: News/Key Developments, 2024
- Table 47 : PacBio: Company Snapshot
- Table 48 : PacBio: Financial Performance, FY 2023 and 2024
- Table 49 : PacBio: Product Portfolio
- Table 50 : PacBio: News/Key Developments, 2023-2024
- Table 51 : Thermo Fisher Scientific Inc.: Company Snapshot
- Table 52 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
- Table 53 : Thermo Fisher Scientific Inc.: Product Portfolio
- Table 54 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023-2025
- Table 55 : List of Few Emerging Startups in the Chinese market for DNA sequencing
List of Figures
- Summary Figure : Chinese Market Shares of DNA Sequencing, by Technology, 2024
- Figure 1 : Porter's Five Forces Analysis of the Chinese DNA Sequencing Market
- Figure 2 : Market Dynamics Snapshot of Chinese DNA Sequencing
- Figure 3 : Chinese Market Shares of DNA Sequencing, by Product and Service, 2024
- Figure 4 : Chinese Market Shares of DNA Sequencing, by Technology, 2024
- Figure 5 : Different NGS Technologies and Their Applications
- Figure 6 : Chinese Market Shares of DNA Sequencing, by Application, 2024
- Figure 7 : Chinese Market Shares of DNA Sequencing, by End User, 2024
- Figure 8 : Chinese Market Shares of DNA Sequencing, by Province, 2024
- Figure 9 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2024
- Figure 10 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2024
- Figure 11 : BGI: Revenue Shares, by Business Unit, FY 2024
- Figure 12 : BGI: Revenue Shares, by Country/Region, FY 2024
- Figure 13 : Burning Rock Dx: Revenue Shares, by Business Segment, FY 2024
- Figure 14 : Burning Rock Dx: Revenue Shares, by Country/Region, FY 2024
- Figure 15 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2024
- Figure 16 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2024
- Figure 17 : Oxford Nanopore Technologies plc: Revenue Shares, by Country/Region, FY 2024
- Figure 18 : PACBIO: Revenue Shares, by Business Unit, FY 2024
- Figure 19 : PACBIO: Revenue Shares, by Country/Region, FY 2024
- Figure 20 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
- Figure 21 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024
